Century Therapeutics (NASDAQ:IPSC) Vs. SWTX, SANA, RLAY, RXRX, VALN, KYMR, IOVA, TIL, ALLO, and IBRX
Should you be buying Century Therapeutics stock or one of its competitors? The main competitors of Century Therapeutics include SpringWorks Therapeutics (SWTX), Sana Biotechnology (SANA), Relay Therapeutics (RLAY), Recursion Pharmaceuticals (RXRX), Valneva (VALN), Kymera Therapeutics (KYMR), Iovance Biotherapeutics (IOVA), Instil Bio (TIL), Allogene Therapeutics (ALLO), and ImmunityBio (IBRX). These companies are all part of the "biological products, except diagnostic" industry.
Century Therapeutics vs.
Century Therapeutics (NASDAQ:IPSC) and Sana Biotechnology (NASDAQ:SANA) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, community ranking, dividends, valuation and analyst recommendations.
Century Therapeutics received 2 more outperform votes than Sana Biotechnology when rated by MarketBeat users. Likewise, 66.67% of users gave Century Therapeutics an outperform vote while only 44.44% of users gave Sana Biotechnology an outperform vote.
Century Therapeutics currently has a consensus price target of $36.00, indicating a potential upside of 136.38%. Sana Biotechnology has a consensus price target of $38.50, indicating a potential upside of 130.95%. Given Century Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Century Therapeutics is more favorable than Sana Biotechnology.
35.2% of Century Therapeutics shares are owned by institutional investors. Comparatively, 50.6% of Sana Biotechnology shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Century Therapeutics' return on equity of 0.00% beat Sana Biotechnology's return on equity.
In the previous week, Century Therapeutics had 2 more articles in the media than Sana Biotechnology. MarketBeat recorded 2 mentions for Century Therapeutics and 0 mentions for Sana Biotechnology. Sana Biotechnology's average media sentiment score of 0.83 beat Century Therapeutics' score of -0.01 indicating that Sana Biotechnology is being referred to more favorably in the news media.
Summary
Century Therapeutics beats Sana Biotechnology on 8 of the 10 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding IPSC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Century Therapeutics (NASDAQ:IPSC) vs. Its Competitors
Century Therapeutics Competitors List
